We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
drug target for type-2 diabetes mellitus and obesity. It is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases ...
Search the most accurate and complete listings in the industry.
Bonus May 31, 2018 Jun 02, 2018 Apr 19, 2018 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Jun 16, 2009 Jun 17, 2009 Apr 20, 2009 Bonus Ratio: 1 share(s) for every 1 shares held Bonus Jul 28, ...
Bonus Sep 27, 1999 Oct 12, 1999 May 26, 1999 Bonus Ratio: 1 share(s) for every 2 shares held Bonus-Jan 03, 1990 Oct 07, 1990 Bonus Ratio: 1 share(s) for every 2 shares held Bonus-Jun 23, 1987 Oct 07, ...
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, discovers and develops tumor-activated immuno-oncology therapies. Its checkpoint inhibitor program includes XTX101, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results